Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.55) per share. This is a 66.67 percent decrease over losses of $(0.33) per share from the same period last year.
A Preview Of Cintas’s Earnings
Cintas (NASDAQ:CTAS) is set to give its latest quarterly earnings report on Thursday, 2023-12-21. Here’s what investors need…